US Stock MarketDetailed Quotes

BRTH Breathe BioMedical

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 29 09:30 ET
0Market Cap0.00P/E (TTM)

Breathe BioMedical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-213.12%-1.59M
-74.00%-5.09M
-507.29K
-6.35%-2.93M
-2.75M
Net income from continuing operations
-188.25%-3.34M
-87.57%-8.36M
---1.16M
-12.28%-4.46M
---3.97M
Depreciation and amortization
43.18%132.85K
78.59%465.2K
--92.79K
18.06%260.48K
--220.63K
Other non cash items
--54.72K
6,895.67%72.69K
----
--1.04K
----
Change In working capital
152.57%1.15M
-29.24%462.76K
--454.97K
124.26%654.01K
--291.63K
-Change in receivables
-139.26%-277.78K
141.96%66.88K
--707.46K
12.08%-159.36K
---181.26K
-Change in prepaid assets
-113.63%-50.7K
35.02%-347
---23.73K
-103.38%-534
--15.82K
-Change in payables and accrued expense
745.92%1.48M
-51.32%396.23K
---228.76K
78.07%813.9K
--457.07K
Cash from discontinued investing activities
Operating cash flow
-213.12%-1.59M
-74.00%-5.09M
---507.29K
-6.35%-2.93M
---2.75M
Investing cash flow
Cash flow from continuing investing activities
-2,859.38%-705.4K
78.83%-127.9K
-23.84K
-159.07%-604.13K
1.02M
Net PPE purchase and sale
-2,859.38%-705.4K
78.83%-127.9K
---23.84K
19.83%-604.13K
---753.61K
Net investment purchase and sale
----
--0
----
--0
--1.78M
Cash from discontinued investing activities
Investing cash flow
-2,859.38%-705.4K
78.83%-127.9K
---23.84K
-159.07%-604.13K
--1.02M
Financing cash flow
Cash flow from continuing financing activities
260.27%3.16M
86.47%6.31M
878.46K
96.54%3.38M
1.72M
Net issuance payments of debt
--2.23M
40.82%878.69K
--0
4,891.70%623.96K
--12.5K
Net common stock issuance
21.62%825.17K
94.26%5.36M
--678.46K
142.73%2.76M
--1.14M
Proceeds from stock option exercised by employees
--106.7K
3,793.39%73.59K
--0
-99.67%1.89K
--572.85K
Net other financing activities
----
----
--200K
----
----
Cash from discontinued financing activities
Financing cash flow
260.27%3.16M
86.47%6.31M
--878.46K
96.54%3.38M
--1.72M
Net cash flow
Beginning cash position
199.27%1.64M
-21.17%546.73K
--546.73K
-0.96%693.56K
--700.25K
Current changes in cash
150.77%871.03K
841.96%1.09M
--347.34K
-2,095.22%-146.84K
---6.69K
End cash Position
180.43%2.51M
199.27%1.64M
--894.06K
-21.17%546.73K
--693.56K
Free cash flow
-331.88%-2.29M
-47.84%-5.22M
---531.12K
-0.72%-3.53M
---3.5M
Currency Unit
CAD
CAD
CAD
CAD
CAD
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -213.12%-1.59M-74.00%-5.09M-507.29K-6.35%-2.93M-2.75M
Net income from continuing operations -188.25%-3.34M-87.57%-8.36M---1.16M-12.28%-4.46M---3.97M
Depreciation and amortization 43.18%132.85K78.59%465.2K--92.79K18.06%260.48K--220.63K
Other non cash items --54.72K6,895.67%72.69K------1.04K----
Change In working capital 152.57%1.15M-29.24%462.76K--454.97K124.26%654.01K--291.63K
-Change in receivables -139.26%-277.78K141.96%66.88K--707.46K12.08%-159.36K---181.26K
-Change in prepaid assets -113.63%-50.7K35.02%-347---23.73K-103.38%-534--15.82K
-Change in payables and accrued expense 745.92%1.48M-51.32%396.23K---228.76K78.07%813.9K--457.07K
Cash from discontinued investing activities
Operating cash flow -213.12%-1.59M-74.00%-5.09M---507.29K-6.35%-2.93M---2.75M
Investing cash flow
Cash flow from continuing investing activities -2,859.38%-705.4K78.83%-127.9K-23.84K-159.07%-604.13K1.02M
Net PPE purchase and sale -2,859.38%-705.4K78.83%-127.9K---23.84K19.83%-604.13K---753.61K
Net investment purchase and sale ------0------0--1.78M
Cash from discontinued investing activities
Investing cash flow -2,859.38%-705.4K78.83%-127.9K---23.84K-159.07%-604.13K--1.02M
Financing cash flow
Cash flow from continuing financing activities 260.27%3.16M86.47%6.31M878.46K96.54%3.38M1.72M
Net issuance payments of debt --2.23M40.82%878.69K--04,891.70%623.96K--12.5K
Net common stock issuance 21.62%825.17K94.26%5.36M--678.46K142.73%2.76M--1.14M
Proceeds from stock option exercised by employees --106.7K3,793.39%73.59K--0-99.67%1.89K--572.85K
Net other financing activities ----------200K--------
Cash from discontinued financing activities
Financing cash flow 260.27%3.16M86.47%6.31M--878.46K96.54%3.38M--1.72M
Net cash flow
Beginning cash position 199.27%1.64M-21.17%546.73K--546.73K-0.96%693.56K--700.25K
Current changes in cash 150.77%871.03K841.96%1.09M--347.34K-2,095.22%-146.84K---6.69K
End cash Position 180.43%2.51M199.27%1.64M--894.06K-21.17%546.73K--693.56K
Free cash flow -331.88%-2.29M-47.84%-5.22M---531.12K-0.72%-3.53M---3.5M
Currency Unit CADCADCADCADCAD

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data